Now Available: LS Prime® Digital | Specialized coverage for digital health companies. One point of contact. Comprehensive protection. Built for innovation. Explore the solution

News and Blog

Navigating the complex intersection of the life sciences industry and insurance

 

Through engaging articles from our industry experts, learn about cutting-edge research, breakthrough discoveries, regulatory compliance, risk management strategies, and much more.

Blog content is current only as of the publication date and may become outdated as laws, regulations, and industry practices evolve. This blog is for general informational purposes only and is not intended as legal or other professional advice. Links to third party websites are provided for convenience only and do not constitute an endorsement of any third-party products, services, or opinions. Berkley Life Sciences is not responsible for the content of external sites. Views expressed are those of the individual author and do not necessarily reflect the views of any Berkley company.

Our most recent News Releases

Probiotics in Live Biotherapeutics: Innovations and Hurdles

Probiotics in Live Biotherapeutics

Probiotics are skyrocketing in popularity. While they are classified as dietary supplements, probiotics are often being marketed and used to treat symptoms and illnesses despite not having FDA approval, which can lead to safety concerns for consumers.

Read More

Navigating Liability Protections for Life Science Companies Under Blood and Tissue Shield Laws

Blood and Tissue Shield Laws

Beginning in the 1960s, medical facilities, blood banks, and other public providers of blood products began seeing limited statutory protections arise in most states through what has become known as “blood shield laws.”

Read More

Psychedelics & Psilocybin: Unlocking Therapeutic Potential

Psychedelics & Psilocybin: Unlocking Therapeutic Potential

Psychedelic drugs have long fascinated humanity, from use in ancient rituals to potential therapeutic benefits. Among these, psilocybin, the active compound in "magic mushrooms," stands out for its historical significance and promising future. This article delves into the legal status, clinical trials, history, and future of psychedelic drugs, with a particular focus on psilocybin.

Read More

Exploring Genetic Testing Privacy: Safeguards and Concerns

Genetic Testing Privacy

Not so long ago, genetic testing was aspirational, a process more common to science fiction than accepted medical research. Over the past several decades, however, genetic testing and gene therapy have become mainstream. 

Read More

Advantages and Challenges of Biodegradable Implants

Biodegradable Implant

Orthopedic and oral/maxillofacial implants currently represent a combined $2.8 billion market, a figure expected to experience significant and continued growth. Although traditional permanent implants have proven clinically efficacious, they are also associated with several drawbacks, including secondary surgeries, infection, and rejection.

Read More

Not Just a Claims Adjuster – A Conversation with Cynthia Khin

Not Just a Claims Adjuster – A Conversation with Cynthia Khin

Recently, Magna Legal Services, a company that provides legal support and consulting services, interviewed Berkley Life Sciences Cynthia "Cindy" Khin, Life Sciences Casualty Resolution Director. The following is their conversation about Cindy’s career path and the importance of mock trials.

Read More

FDA Draft Guidance for Misinformation – Part 2

FDA Draft Guidance for Misinformation – Part 2

In a previous post, we discussed the FDA’s July 2024 Draft Guidance entitled "Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers" (the "Draft Guidance"). The Draft Guidance suggests a purportedly voluntary pathway for drug and device sponsors, manufacturers, distributors, and other stakeholders legally responsible for the labeling of approved/cleared medical products ("firms") to respond to internet-based posts and comments in a manner consistent with existing product labeling and advertising laws.


Read More

Preventing Medical Device Shortages Through Improving the United States Sterilization Supply Chain

A surgeon handles sterilized medical equipment

Both Ethylene Oxide (EtO) and gamma radiation are highly effective sterilizers for medical devices, but they face significant supply chain vulnerabilities that have already led to shortages within the United States. To mitigate these risks and bolster the sterilization supply chain, the FDA recently approved a new “Established Category A” sterilization method and implemented three key programs designed to encourage medical device manufacturers to adopt alternative methods, all within the last five years (FDA, 2024).


Read More

The Growth of Digital Health – Exploring the Driving Forces Behind its Expansion

A patient uses a continuous glucose monitor to check their blood sugar

Digital health technology is experiencing a period of unprecedented growth and innovation. The global digital health market is projected to expand from $309B in 2023 to $1,019B by 2032 with a Compound Annual Growth Rate (CAGR) of 12%. Europe is reportedly the largest market, while Asia Pacific is the fastest-growing region. Although many factors contribute to this significant market growth, advancements in robotics, artificial intelligence, and remote monitoring devices stand out as primary driving forces.


Read More

The Evolution of Benzene Litigation & Considerations for Product Manufacturers

Benzene chemical structure

This blog post discusses the origin of benzene litigation, how third-party research and subsequent citizens petitions drive modern benzene claims, and steps manufacturers can consider in assessing risk and preparing to defend against potential benzene lawsuits.


Read More

Subscribe to Our Blog

Be the first to receive exclusive life science articles directly to your inbox. Monthly news articles include interviews, webinars and insights from life science experts.

The information you provide will be used in accordance with the terms of our privacy policy.

Opens email application

Opens in new tab